Eli Lilly to Acquire Ajax Therapeutics in Deal Worth Up to $2.3 Billion
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, strengthening its pipeline in blood cancer treatments.
Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, strengthening its pipeline in blood cancer treatments.
Microsoft will lose exclusive rights to OpenAI models, allowing broader distribution as the partnership evolves and revenue-sharing terms change.
A U.S. government investment in Intel has generated $25.7 billion in unrealized gains in just eight months after shares surged following earnings.
China has blocked Meta’s $2 billion acquisition of AI startup Manus, citing regulatory concerns over the cross-border deal.
SanDisk shares have surged 3000% over the past year as demand for AI data center storage fuels explosive growth.
Sun Pharma shares rose 7% after announcing an $11.75 billion deal to acquire U.S.-based Organon, expanding its global footprint.
Microsoft is introducing its first voluntary buyout program, targeting up to 7% of its U.S. workforce as part of broader efficiency efforts.
TSMC shares reached a record high after Taiwan eased single-stock investment caps, boosting demand from institutional funds.
OpenAI released GPT-5.5 with improved efficiency and a focus on agentic coding, though higher pricing reflects its expanded capabilities.
Tesla has started Cybercab production in Texas without volume restrictions, signaling a major step in scaling its autonomous vehicle strategy.
Anthropic is trading at a $1 trillion valuation on secondary markets, surpassing OpenAI and highlighting shifting investor sentiment in AI.
FTX’s investment portfolio could be worth $114 billion today if assets hadn’t been sold during its 2022 collapse, driven by massive gains in AI and tech holdings.
American Airlines lowered its 2026 earnings forecast as rising jet fuel prices significantly increased operating costs.